Hepion expands share authorization: what it means for Hepion Pharmaceuticals stock

Published on 10/05/2026 at 08:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hepion authorized 750,000,000 shares on October 1, 2026. Hepion Pharmaceuticals stock was USD 0.08 on October 2, 2026 versus USD 0.12 high.

HEPA, US4268974015, Illustration mit AI erstellt.

Hepion Pharmaceuticals (US4268974015) increased its authorized common shares to 750,000,000 effective October 1, 2026. The change matters because the company is building financing capacity while existing holders face potential dilution if additional securities are issued.

Share capacity reaches 750 million

According to StockTitan on October 2, 2026, Hepion filed a Certificate of Amendment that raised the authorized common-share count to 750,000,000. The filing states that the amendment became effective upon filing on October 1, 2026.

The decision follows a financing structure disclosed for September 3, 2026. StockTitan reports that Hepion issued a USD 500,000 secured convertible note and a warrant for 12,500,000 common shares to Gravitas Capital LP.

Dilution math explains what it means

The note carries 8.00 percent annual interest payable in kind and matures on September 3, 2027, while the warrant has an exercise price of USD 0.06 per share and expires on September 3, 2031. Conversion of the note at USD 0.04 per share and exercise of the warrant require stockholder approval of the larger authorized share pool.

That structure gives Hepion additional capital access but also links financing flexibility to future share issuance. The potential warrant shares equal 12,500,000, or 1.67 percent of the new 750,000,000 authorization, before any note conversion and before other securities are considered.

Cash position remains central

Hepion reported USD 1.6 million of cash and equivalents as of June 30, 2026, while second-quarter operating cash flow was negative USD 1.4 million, according to StockTitan. The financing therefore sits alongside a reported cash balance that was only 1.17 times the quarter's operating cash outflow.

HEPA market profile

HEPA was last quoted at USD 0.08 on the OTC QB on October 2, 2026. The 52-week range was USD 0.03 to USD 0.12, placing the quote 33.33 percent below the high, while market capitalization stood at USD 0.9 million.